RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT
Randomised Controlled Trial to Investigate the Effects of an Exercise Programme on Physical Performance and Quality of Life After a Bone Marrow Transplant
1 other identifier
interventional
66
1 country
1
Brief Summary
The hypothesis is that exercise will improve the physical performance and quality of life of bone marrow/ haemopoietic stem cell transplants.The aim of the trial is to provide definite clinical evidence as to which( if any) type of exercise is most beneficial for this patient population. It is also aimed at improving the provision of physiotherapy services to this group of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 11, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedJanuary 8, 2016
January 1, 2016
6.1 years
September 11, 2005
January 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Physical performance.
At 6 weeks
Quality of Life.
At 6 weeks
Anthropometry and Grip strength
At 6 weeks
Secondary Outcomes (2)
Heart Rate.
At 6 weeks
No adverse events during treatment.
At 6 weeks
Study Arms (3)
Aerobic exercise plus resistance
ACTIVE COMPARATORAerobic exercise plus resistance exercise for 6 weeks
Aerobic exercise
ACTIVE COMPARATORAerobic exercise for 6 weeks
Control
OTHERNo formal exercise and weekly phone calls
Interventions
Eligibility Criteria
You may qualify if:
- Recipient bone marrow transplant Alfred Hospital, Platelets \>= 20 x 10E9 / l Provide written consent, 30 days after a bone marrow transplant have an absolute neutrophil count of 1x10E9/l be in a stable medical condition
You may not qualify if:
- febrile neutropenia Have active graft versus host disease Have cardiomyopathy (ejection fraction \< 20%) require \> 28% oxygen
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayside Healthlead
- The Alfredcollaborator
- The Leukaemia Foundation of Victoriacollaborator
Study Sites (1)
Alfred hospital Physiotherapy dept,
Melbourne, Victoria, 3004, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine M Walsh, dip. physio
Bayside Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2005
First Posted
September 14, 2005
Study Start
November 1, 2003
Primary Completion
December 1, 2009
Last Updated
January 8, 2016
Record last verified: 2016-01